Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037875440> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W3037875440 endingPage "160" @default.
- W3037875440 startingPage "140" @default.
- W3037875440 abstract "Fast-acting insulin aspart (faster aspart) is insulin aspart (IAsp) with two added excipients, L-arginine and niacinamide, to ensure formulation stability with accelerated initial absorption after subcutaneous administration compared with previously developed rapid-acting insulins. The pharmacokinetic/pharmacodynamic properties of faster aspart have been characterised in clinical pharmacology trials with comparable overall methodology. In subjects with type 1 (T1D) or type 2 (T2D) diabetes, the serum IAsp concentration-time and glucose-lowering effect profiles are left-shifted for faster aspart compared with IAsp. In addition, faster aspart provides earlier onset, doubling of initial exposure, and an up to 2.5-fold increase in initial glucose-lowering effect within 30 min of subcutaneous injection, as well as earlier offset of exposure and effect. Similar results have been shown using continuous subcutaneous insulin infusion (CSII). The improved pharmacological properties of faster aspart versus IAsp are consistent across populations, i.e. in the elderly, children, adolescents and the Japanese. Thus, the faster aspart pharmacological characteristics more closely resemble the mealtime insulin secretion in healthy individuals, giving faster aspart the potential to further improve postprandial glucose control in subjects with diabetes. Indeed, change from baseline in 1-h postprandial glucose increment is in favour of faster aspart versus IAsp when used as basal-bolus or CSII treatment in phase III trials in subjects with T1D or T2D. This review summarises the currently published results from clinical pharmacology trials with faster aspart and discusses the potential clinical benefits of faster aspart compared with previous rapid-acting insulin products." @default.
- W3037875440 created "2020-07-02" @default.
- W3037875440 creator A5065775242 @default.
- W3037875440 creator A5084566354 @default.
- W3037875440 date "2020-06-26" @default.
- W3037875440 modified "2023-10-16" @default.
- W3037875440 title "Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences" @default.
- W3037875440 doi "https://doi.org/10.14341/dm12357" @default.
- W3037875440 hasPublicationYear "2020" @default.
- W3037875440 type Work @default.
- W3037875440 sameAs 3037875440 @default.
- W3037875440 citedByCount "0" @default.
- W3037875440 crossrefType "journal-article" @default.
- W3037875440 hasAuthorship W3037875440A5065775242 @default.
- W3037875440 hasAuthorship W3037875440A5084566354 @default.
- W3037875440 hasBestOaLocation W30378754401 @default.
- W3037875440 hasConcept C111113717 @default.
- W3037875440 hasConcept C112705442 @default.
- W3037875440 hasConcept C126322002 @default.
- W3037875440 hasConcept C134018914 @default.
- W3037875440 hasConcept C2776664568 @default.
- W3037875440 hasConcept C2778199505 @default.
- W3037875440 hasConcept C2779306644 @default.
- W3037875440 hasConcept C2779908123 @default.
- W3037875440 hasConcept C2781232474 @default.
- W3037875440 hasConcept C3019948211 @default.
- W3037875440 hasConcept C555293320 @default.
- W3037875440 hasConcept C71924100 @default.
- W3037875440 hasConcept C98274493 @default.
- W3037875440 hasConceptScore W3037875440C111113717 @default.
- W3037875440 hasConceptScore W3037875440C112705442 @default.
- W3037875440 hasConceptScore W3037875440C126322002 @default.
- W3037875440 hasConceptScore W3037875440C134018914 @default.
- W3037875440 hasConceptScore W3037875440C2776664568 @default.
- W3037875440 hasConceptScore W3037875440C2778199505 @default.
- W3037875440 hasConceptScore W3037875440C2779306644 @default.
- W3037875440 hasConceptScore W3037875440C2779908123 @default.
- W3037875440 hasConceptScore W3037875440C2781232474 @default.
- W3037875440 hasConceptScore W3037875440C3019948211 @default.
- W3037875440 hasConceptScore W3037875440C555293320 @default.
- W3037875440 hasConceptScore W3037875440C71924100 @default.
- W3037875440 hasConceptScore W3037875440C98274493 @default.
- W3037875440 hasIssue "2" @default.
- W3037875440 hasLocation W30378754401 @default.
- W3037875440 hasLocation W30378754402 @default.
- W3037875440 hasOpenAccess W3037875440 @default.
- W3037875440 hasPrimaryLocation W30378754401 @default.
- W3037875440 hasRelatedWork W1599472676 @default.
- W3037875440 hasRelatedWork W1964773646 @default.
- W3037875440 hasRelatedWork W2070818248 @default.
- W3037875440 hasRelatedWork W2080135029 @default.
- W3037875440 hasRelatedWork W2081239230 @default.
- W3037875440 hasRelatedWork W2129737421 @default.
- W3037875440 hasRelatedWork W2153745306 @default.
- W3037875440 hasRelatedWork W2355805719 @default.
- W3037875440 hasRelatedWork W2374483849 @default.
- W3037875440 hasRelatedWork W2891930321 @default.
- W3037875440 hasVolume "23" @default.
- W3037875440 isParatext "false" @default.
- W3037875440 isRetracted "false" @default.
- W3037875440 magId "3037875440" @default.
- W3037875440 workType "article" @default.